Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963810 | Vaccine | 2015 | 8 Pages |
Abstract
The candidate trivalent PPrV was safe and immunogenic in adults, toddlers, and infants. Addition of aluminum adjuvant improved immunogenicity in infants without changing the safety profile.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
W. Abdullah Brooks, Lee-Jah Chang, Xiaohua Sheng, Robert Hopfer, on behalf of the PPR02 Study Team on behalf of the PPR02 Study Team,